ConductScience.org, home

Paper6301976

Cytolysis of Sendai virus-infected guinea-pig cells by homologous complement.

Okada H and 2 others. Immunology, 1983. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Cytolysis of Sendai virus-infected guinea-pig cells by homologous complement. Papers, record 6301976. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6301976

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Cytolysis of Sendai virus-infected guinea-pig cells by homologous complement.
PubMed
Journal
Immunology
PubMed
Year
1983
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
2
iCite
Relative citation ratio, by iCite
0.09
iCite
Revised in PubMed
2018-11-13
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Okada HH
2Tanaka HH
3Okada NN

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Complement ActivationMajor topic
Complement Pathway, AlternativeMajor topic
Complement System ProteinsMajor topic
Cytotoxicity, ImmunologicMajor topic
Liver Neoplasms, ExperimentalMajor topic
Parainfluenza Virus 1, HumanMajor topic
Animals
Cell Line
Elapid Venoms
Guinea Pigs
Male
Ultraviolet Rays

Source PubMed

Download CSV of topics

References17

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
15919620A new concept of immunosuppression in hypersensitivity reactions and in transplantation immunity.Surv Ophthalmol1966https://conductscience.org/library/papers/5919620PubMed
26946459Homologous species restriction in lysis of erythrocytes by terminal complement proteins.Proc Natl Acad Sci U S A1981https://conductscience.org/library/papers/6946459PubMed
34117012Mechanism of cytolysis by complement.Proc Natl Acad Sci U S A1972https://conductscience.org/library/papers/4117012PubMed
44351395Lysis of tumor cells by antibody and complement. 1. Lack of correlation between antigen content and lytic susceptibility.J Natl Cancer Inst1973https://conductscience.org/library/papers/4351395PubMed
54589989Complement-dependent B-cell activation by cobra venom factor and other mitogens?J Exp Med1974https://conductscience.org/library/papers/4589989PubMed
64522910Rosette formation of human erythrocytes on cultured cells of tumour origin and activation of complement by cell membrane.Nature1974https://conductscience.org/library/papers/4522910PubMed
7207650Lysis of RSV-transformed Japanese quail cells by a factor from normal quail serum.Int J Cancer1978https://conductscience.org/library/papers/207650PubMed
8211040Activation of the alternative complement pathway by human B cell lymphoma lines is associated with Epstein-Barr virus transformation of the cells.Eur J Immunol1978https://conductscience.org/library/papers/211040PubMed
9308935Activation of complement by spontaneous leukemic cells of AKR mice.Int J Cancer1978https://conductscience.org/library/papers/308935PubMed
10228167Activation of the alternative pathway of guinea pig complement by Sendai virus-treated cells.Microbiol Immunol1979https://conductscience.org/library/papers/228167PubMed
11293688Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membrane.Proc Natl Acad Sci U S A1979https://conductscience.org/library/papers/293688PubMed
126928644Antibody-independent activation of the alternative complement pathway by measles virus-infected cells.Proc Natl Acad Sci U S A1980https://conductscience.org/library/papers/6928644PubMed
136967510Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocyte, B lymphocyte, and monocyte.J Exp Med1980https://conductscience.org/library/papers/6967510PubMed
147416718Ability to activate the alternative complement pathway acquired by human and guinea-pig erythrocytes after contact with influenza virus.Ann Immunol (Paris)1980https://conductscience.org/library/papers/7416718PubMed
156265347Sendai virus infected cells are readily cytolysed by guinea-pig complement without antibody.Immunology1981https://conductscience.org/library/papers/6265347PubMed
166913607Purification from guinea pig erythrocyte stroma of a decay-accelerating factor for the classical c3 convertase, C4b,2a.J Immunol1981https://conductscience.org/library/papers/6913607PubMed
174324814Suppression of tumor growth at the site of infection with living Bacillus Calmette-Guérin.J Natl Cancer Inst1971https://conductscience.org/library/papers/4324814PubMed

Download CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn PapersSource
3594492Sensitization of human tumor cells to homologous complement by vaccinia virus treatment.Cancer Immunol Immunother1987https://conductscience.org/library/papers/3594492PubMed
2511185Tumor cells treated with vaccinia virus can activate the alternative pathway of mouse complement.Jpn J Cancer Res1989https://conductscience.org/library/papers/2511185PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6301976

GET https://conductscience.org/api/papers/v1/6301976/authors